[Effects of Porphyromonas gingivalis lipopolysaccharide on apoptotic genes in foam cells]

Zhonghua Kou Qiang Yi Xue Za Zhi. 2010 May;45(5):274-8.
[Article in Chinese]

Abstract

Objective: To investigate the effects of Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on apoptotic genes in foam cells.

Methods: Macrophages from THP-1 monocytes and foam cells from macrophages by oxLDL inducement were treated with oxidized low density lipoprotein (oxLDL) or oxLDL+ Pg-LPS. Cell apoptosis was detected by acridine orange-ethidium bromide (AO-EB) staining. Eleven atherosclerotic related apoptotic genes were examined with polymerase chain reaction (PCR) array, and apoptotic gene p53, c-Myc and caspase-3 were evaluated with real-time PCR.

Results: Pg-LPS enhanced cell apoptosis rate during and after foam cells formation [(5.47+/-0.93)% vs. (7.50+/-0.54)%]. PCR array demonstrated that it increased B-cell CLL-lymphoma 2 (BCL2) related protein A1 (BCL2A1) transcription during foam cells formation (>2 fold), and promoted BCL2 and BCL2A1 transcription after foam cells formation (>2 fold). It promoted p53 and caspase-3 transcription level (4.50x10(-3)+/-4.02x10(-4) vs. 5.30x10(-2)+/-4.58x10(-3)), whereas inhibited c-Myc transcription level (1.53x10(-2)+/-5.77x10(-4)) during foam cells formation. It promoted caspase-3 transcription (6.00x10(-2)+/-6.08x10(-3)), and inhibited p53 transcription (4.23x10(-3)+/-5.85x10(-4)) after foam cells formation.

Conclusions: Pg-LPS affected apoptotic gene transcription during and after foam cells formation and enhanced cell apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Foam Cells / cytology*
  • Foam Cells / drug effects
  • Foam Cells / metabolism
  • Gene Expression
  • Humans
  • Lipopolysaccharides / isolation & purification
  • Lipopolysaccharides / pharmacology*
  • Lipoproteins, LDL / pharmacology
  • Macrophages / physiology
  • Minor Histocompatibility Antigens
  • Porphyromonas gingivalis* / chemistry
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Proto-Oncogene Proteins c-myc / metabolism
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • BCL2-related protein A1
  • Lipopolysaccharides
  • Lipoproteins, LDL
  • Minor Histocompatibility Antigens
  • Proto-Oncogene Proteins c-bcl-2
  • Proto-Oncogene Proteins c-myc
  • Tumor Suppressor Protein p53
  • oxidized low density lipoprotein
  • Caspase 3